Tayfun Güngör, Titular Professor of Pediatrics and Stem Cell Transplantation at the University Children’s Hospital Zurich, shared on LinkedIn:
“Big milestone for our SCT and Oncology teams at the University Children’s Hospital Zurich!
We have officially been re-accredited by EBMT-JACIE for:
- Autologous and allogeneic stem cell transplants (pediatric)
- Bone marrow collection
- Peripheral blood stem cell apheresis
- Cell processing
- And for the very first time: The administration of immune effector cells (IEC)!
Realizing this achievement in our brand-new premises makes it even more special.
A huge thank you to our entire multidisciplinary team – doctors, nurses, coordinators, data managers, pharmacists, lab and apheresis technicians. Your dedication over the past years made this success story possible!
Congratulations to everyone involved!”
You can also read: ‘FDA Approves Tregzi, the First Regulatory T-Cell Therapy for Allogeneic HSCT‘
